Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malaria

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 115 articles: HTML format

Single Articles

April 2024
1. GRAUMANS W, Ayo D, van Lieshout N, Lanke K, et al
   Plasmodium malariae and Plasmodium ovale-Prevalent and Relevant.
   J Infect Dis. 2024;229:1239-1240.
   PubMed    
   
   
   March 2024
2. ADJEMOUT M, Gallardo F, Torres M, Thiam A, et al
   From GWAS to functional variants: ARL14 cis-regulatory variants are associated with severe malaria.
   J Infect Dis. 2024 Mar 26:jiae159. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. WESTERCAMP N, Osei-Tutu L, Schuerman L, Kariuki SK, et al
   Could less be more? Accounting for fractional-dose regimens and different number of vaccine doses when measuring the impact of the RTS, S/AS01E malaria vaccine.
   J Infect Dis. 2024 Mar 4:jiae075. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2024
4. FRIEDMAN-KLABANOFF DJ, Berry AA, Travassos MA, Shriver M, et al
   Recombinant full-length Plasmodium falciparum circumsporozoite protein-based vaccine adjuvanted with GLA-LSQ: Results of Phase 1 testing with malaria challenge.
   J Infect Dis. 2024 Feb 8:jiae062. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. FONTOURA PS, Macedo EG, Calil PR, Corder RM, et al
   Changing Clinical Epidemiology of Plasmodium vivax Malaria as Transmission Decreases: Population-Based Prospective Panel Survey in the Brazilian Amazon.
   J Infect Dis. 2024 Feb 7:jiad456. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2024
6. SCHWAKE CJ, Krueger RM, Hanada T, Chishti AH, et al
   Plasmodium falciparum glutamic acid-rich protein (PfGARP)-independent polyclonal antibodies inhibit malaria parasite growth in human erythrocytes.
   J Infect Dis. 2024 Jan 31:jiae050. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. SILVA NI, Souza PFL, Silva BF, Fonseca SG, et al
   Host transcriptional meta-signatures reveal diagnostic biomarkers for Plasmodium falciparum malaria.
   J Infect Dis. 2024 Jan 25:jiae041. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. OLEINIKOV AV, Seidu Z, Oleinikov IV, Tetteh M, et al
   Profiling the Plasmodium falciparum Erythrocyte Membrane Protein 1-Specific Immununoglobulin G Response Among Ghanaian Children With Hemoglobin S and C.
   J Infect Dis. 2024;229:203-213.
   PubMed     Abstract available
   
   
   December 2023
9. MUFUMBA I, Kazinga C, Namazzi R, Opoka RO, et al
   sTREM-1: a biomarker of mortality in severe malaria impacted by acute kidney injury.
   J Infect Dis. 2023 Dec 11:jiad561. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. BARO B, Bassat Q
    sTREM-1 to risk-stratify patients with malaria: A functional crystal ball to improve outcomes and save lifes.
    J Infect Dis. 2023 Dec 11:jiad565. doi: 10.1093.
    PubMed    
    
    
    
11. MALLA P, Wang Z, Brashear A, Yang Z, et al
    Effectiveness of unsupervised primaquine regimen for preventing Plasmodium vivax malaria relapses in northeast Myanmar, a single-arm non-randomized observational study.
    J Infect Dis. 2023 Dec 2:jiad552. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
12. POPKIN HALL ZR, Seth MD, Madebe RA, Budodo R, et al
    Malaria species positivity rates among symptomatic individuals across regions of differing transmission intensities in Mainland Tanzania.
    J Infect Dis. 2023 Nov 22:jiad522. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. ZAYET S, Hagenkotter B, Quadrio I, Gendrin V, et al
    Correspondence on 'Neurofilament light chain as a biomarker of neuronal damage in children with malaria'.
    J Infect Dis. 2023 Nov 9:jiad489. doi: 10.1093.
    PubMed    
    
    
    
14. THONGPOON S, Roobsoong W, Nguitragool W, Chotirat S, et al
    Naturally acquired transmission-blocking immunity against different strains of Plasmodium vivax in a malaria endemic area in Thailand.
    J Infect Dis. 2023 Nov 7:jiad469. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
15. JAIROCE C, Macia D, Torres-Yaguana JP, Mayer L, et al
    RTS, S/AS02A malaria vaccine-induced IgG responses equally recognize native-like fucosylated and non-fucosylated Plasmodium falciparum circumsporozoite proteins.
    J Infect Dis. 2023 Oct 27:jiad471. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. JOSTE V, Colard-Itte E, Guillochon E, Ariey F, et al
    Genetic Profiling of Plasmodium ovale wallikeri Relapses With Microsatellite Markers and Whole-Genome Sequencing.
    J Infect Dis. 2023;228:1089-1098.
    PubMed     Abstract available
    
    
    September 2023
17. ZENO EE, Obala AA, Pence B, Freedman E, et al
    Risk of malaria following untreated sub-patent Plasmodium falciparum infections: Results over 4 years from a cohort in a high transmission area in Western Kenya.
    J Infect Dis. 2023 Sep 15:jiad398. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. TRAORE K, Coulibaly D, Kone AK, Guindo B, et al
    Randomized field trial to assess the safety and efficacy of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in school-aged children in Bandiagara, Mali.
    J Infect Dis. 2023 Sep 8:jiad387. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2023
19. BALANZA N, Francis CK, Crowley VM, Weckman AM, et al
    Neurofilament light chain as a biomarker of neuronal damage in children with malaria.
    J Infect Dis. 2023 Aug 30:jiad373. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. XU E, Goel V, Baguma E, Ayebare E, et al
    Evolution of spatial risk of malaria infection after a pragmatic chemoprevention program in response to severe flooding in rural western Uganda.
    J Infect Dis. 2023 Aug 16:jiad348. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. NALWOGA A, Sabourin KR, Miley W, Jackson C, et al
    Plasmodium falciparum malaria is associated with increased KSHV seropositivity and higher KSHV antibody breadth and magnitude: results of a case-control study from rural Uganda.
    J Infect Dis. 2023 Aug 4:jiad308. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
22. SAMAYOA-REYES G, Weigel C, Koech E, Waomba K, et al
    Effect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children.
    J Infect Dis. 2023 Jul 11:jiad264. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
23. BARUA P, Duffy MF, Manning L, Laman M, et al
    Antibody to Plasmodium falciparum variant surface antigens, var gene transcription and ABO blood group in children with severe or uncomplicated malaria.
    J Infect Dis. 2023 Jun 21:jiad217. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2023
24. ROH ME, Zongo I, Haro A, Huang L, et al
    Seasonal malaria chemoprevention drug levels and drug resistance markers in children with or without malaria in Burkina Faso: a case control study.
    J Infect Dis. 2023 May 23:jiad172. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. SIBLEY CH
    A Breakthrough: Defining Plasmodium vivax Drug Resistance Genes.
    J Infect Dis. 2023;227:1119-1120.
    PubMed    
    
    
    April 2023
26. NZIZA N, Tran TM, DeRiso EA, Dolatshahi S, et al
    Accumulation of Neutrophil Phagocytic Antibody Features Tracks With Naturally Acquired Immunity Against Malaria in Children.
    J Infect Dis. 2023 Apr 26:jiad115. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. CHALLENGER JD, van Beek SW, Ter Heine R, van der Boor SC, et al
    Modelling the impact of a highly potent Plasmodium falciparum transmission-blocking monoclonal antibody in areas of seasonal malaria transmission.
    J Infect Dis. 2023 Apr 12:jiad101. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. ALEMNJI G, Mosha F, Maggiore P, Alexander H, et al
    Building Integrated Testing Programs for Infectious Diseases.
    J Infect Dis. 2023 Apr 12:jiad103. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2023
29. BHARDWAJ J, Upadhye A, Gaskin EL, Doumbo S, et al
    Neither the African-centric S47 nor P72 variant of TP53 is associated with reduced risk of febrile malaria in a Malian cohort study.
    J Infect Dis. 2023 Mar 24:jiad066. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
30. ANABIRE NG, Quintana MDP, Ofori MF, Hviid L, et al
    The rapid and spontaneous post-partum clearance of Plasmodium falciparum is related to expulsion of the placenta.
    J Infect Dis. 2023 Feb 6:jiad031. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2022
31. BLANKSON SO, Dikroh L, Tettey P, Tornyigah B, et al
    The EPCR rs867186 gene polymorphism is associated with increased level of soluble EPCR and high risk of severe malaria and fatality in Beninese children.
    J Infect Dis. 2022 Nov 23:jiac461. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
32. JARAMILLO-UNDERWOOD A, Impoinvil D, Sutcliff A, Hamre KES, et al
    Factors Associated With Human IgG Antibody Response to Anopheles albimanus Salivary Gland Extract, Artibonite Department, Haiti, 2017.
    J Infect Dis. 2022;226:1461-1469.
    PubMed     Abstract available
    
    
    September 2022
33. CONROY AL, Tran TM, Bond C, Opoka RO, et al
    Plasma amino acid concentrations in children with severe malaria are associated with mortality and worse long-term kidney and cognitive outcomes.
    J Infect Dis. 2022 Sep 30. pii: 6732500. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. WICHT KJ, Small-Saunders JL, Hagenah LM, Mok S, et al
    Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials.
    J Infect Dis. 2022 Sep 9. pii: 6694676. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. ZHOU G, Hemming-Schroeder E, Jeang B, Wang X, et al
    Irrigation-induced environmental changes sustain malaria transmission and compromise intervention effectiveness.
    J Infect Dis. 2022 Sep 3. pii: 6691386. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
36. CUTTS JC, O'Flaherty K, Zaloumis SG, Ashley EA, et al
    Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia.
    J Infect Dis. 2022;226:324-331.
    PubMed     Abstract available
    
    
    
37. NGAI M, Hawkes MT, Erice C, Weckman AM, et al
    Intestinal injury in Ugandan children hospitalized with malaria.
    J Infect Dis. 2022 Aug 9. pii: 6658539. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2022
38. BELL GJ, Goel V, Essone P, Dosoo D, et al
    Malaria Transmission Intensity Likely Modifies RTS, S/AS01 Efficacy Due to a Rebound Effect in Ghana, Malawi, and Gabon.
    J Infect Dis. 2022 Jul 28. pii: 6650987. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. JOHN CC
    What can twins teach us about malaria epidemiology?
    J Infect Dis. 2022 Jul 18. pii: 6645932. doi: 10.1093.
    PubMed    
    
    
    
40. GONCALVES BP, Perez-Caballero R, Barry A, Gaoussou S, et al
    Natural history of malaria infections during early childhood in twins.
    J Infect Dis. 2022 Jul 18. pii: 6645931. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. SAMUELS AM, Towett O, Seda B, Wiegand RE, et al
    Diagnostic performance of loop-mediated isothermal amplification and ultra-sensitive rapid diagnostic tests for malaria screening among pregnant women in Kenya.
    J Infect Dis. 2022 Jul 11. pii: 6639436. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2022
42. NAIR S, Li X, Nkhoma SC, Anderson T, et al
    Fitness costs of pfhrp2 and pfhrp3 deletions underlying diagnostic evasion in malaria parasites.
    J Infect Dis. 2022 Jun 16. pii: 6609446. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. BLATT DB, Hanisch B, Co K, Datta D, et al
    Impact of oxidative stress on risk of death and readmission in African children with severe malaria: a prospective observational study.
    J Infect Dis. 2022 Jun 9. pii: 6604811. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
44. 
    Correction to: Flowcytometric and ImageStream RNA-FISH Gene Expression, Quantification and Phenotypic Characterization of Blood Stages and Sporozoites From Human Malaria Species.
    J Infect Dis. 2022 May 27. pii: 6594174. doi: 10.1093.
    PubMed    
    
    
    
45. REK J, Blanken SL, Okoth J, Ayo D, et al
    Asymptomatic school-aged children are important drivers of malaria transmission in a high endemicity setting in Uganda.
    J Infect Dis. 2022 May 17. pii: 6586673. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. HEMPEL C, Milner D, Seydel K, Taylor T, et al
    Specific components associated with the endothelial glycocalyx are lost from brain capillaries in cerebral malaria.
    J Infect Dis. 2022 May 12. pii: 6584746. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
47. MEIWALD A, Clark E, Kristan M, Edi C, et al
    Association of Reduced Long-Lasting Insecticidal Net Efficacy and Pyrethroid Insecticide Resistance With Overexpression of CYP6P4, CYP6P3, and CYP6Z1 in Populations of Anopheles coluzzii From Southeast Cote d'Ivoire.
    J Infect Dis. 2022;225:1424-1434.
    PubMed     Abstract available
    
    
    
48. WAMAE K, Kimenyi KM, Osoti V, de Laurent ZR, et al
    Amplicon sequencing as a potential surveillance tool for complexity of infection and drug resistance markers in Plasmodium falciparum asymptomatic infections.
    J Infect Dis. 2022 Apr 16. pii: 6569362. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. COLLINS KA, Ceesay S, Drammeh S, Jaiteh FK, et al
    A cohort study on the duration of Plasmodium falciparum infections during the dry season in The Gambia.
    J Infect Dis. 2022 Apr 5. pii: 6563452. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
50. SHARMA A, Jenkins B, Akue A, Lambert LE, et al
    Plasmodium falciparum in Aotus nancymaae: A New Model for Placental Malaria.
    J Infect Dis. 2022 Mar 15. pii: 6549045. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. COHEE LM, Peterson I, Buchwald AG, Coalson JE, et al
    School-based malaria screening and treatment reduces Plasmodium falciparum infection and anemia prevalence in two transmission settings in Malawi.
    J Infect Dis. 2022 Mar 15. pii: 6549047. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. COLLINS KA, Abd-Rahman AN, Marquart L, Ballard E, et al
    Antimalarial Activity of Artefenomel Against Asexual Parasites and Transmissible Gametocytes During Experimental Blood-Stage Plasmodium vivax Infection.
    J Infect Dis. 2022;225:1062-1069.
    PubMed     Abstract available
    
    
    
53. GUILLOCHON E, Fraering J, Joste V, Kamaliddin C, et al
    Transcriptome analysis of Plasmodium falciparum isolates from Benin reveals specific gene expression associated with cerebral malaria.
    J Infect Dis. 2022 Mar 7. pii: 6543891. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. MCDOWELL D, Hurt L, Kabatereine NB, Stothard JR, et al
    Infection history and current co-infection with Schistosoma mansoni decreases Plasmodium species intensities in pre-school children from Uganda.
    J Infect Dis. 2022 Mar 5. pii: 6542725. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. KAMAU E, Bennett JW, Yadava A
    Response to Odedra et al.
    J Infect Dis. 2022;225:927-928.
    PubMed    
    
    
    January 2022
56. KOLADJO BF, Yovo E, Accrombessi M, Agbota G, et al
    Malaria in the first trimester of pregnancy and fetal growth: results from a Beninese pre-conceptional cohort.
    J Infect Dis. 2022 Jan 28. pii: 6516776. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
57. KESWANI T, Obeidallah A, Nieves E, Sidoli S, et al
    Pipecolic acid, a putative mediator of the encephalopathy of cerebral malaria and the experimental model of cerebral malaria.
    J Infect Dis. 2021 Dec 21. pii: 6473446. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. LEUBA SI, Westreich D, Bose CL, Powers KA, et al
    Predictors of Plasmodium falciparum infection in the first trimester among nulliparous women from Kenya, Zambia, and the Democratic Republic of the Congo.
    J Infect Dis. 2021 Dec 9. pii: 6458120. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. DE OLIVEIRA TC, Rodrigues PT, Early AM, Duarte AMRC, et al
    Plasmodium simium: Population Genomics Reveals the Origin of a Reverse Zoonosis.
    J Infect Dis. 2021;224:1950-1961.
    PubMed     Abstract available
    
    
    October 2021
60. KEITANY GJ, Jenkins BJ, Obiakor HT, Daniel S, et al
    An invariant protein that co-localizes with VAR2CSA on Plasmodium falciparum-infected red cells binds to chondroitin sulfate A.
    J Infect Dis. 2021 Oct 29. pii: 6414212. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. KYEI-BAAFOUR E, Kusi KA, Arthur FKN, Sarkodie-Addo T, et al
    IgG3 hinge region length polymorphism is associated with cerebral malaria in Ghanaian children.
    J Infect Dis. 2021 Oct 28. pii: 6413721. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. KEPPLE D, Hubbard A, Ali MM, Abargero BR, et al
    Plasmodium vivax From Duffy-Negative and Duffy-Positive Individuals Share Similar Gene Pools in East Africa.
    J Infect Dis. 2021;224:1422-1431.
    PubMed     Abstract available
    
    
    
63. LEONARD CM, Assefa A, Sime H, Mohammed H, et al
    Spatial distribution of Plasmodium falciparum and P. vivax in northern Ethiopia by microscopy, rapid diagnostic test, laboratory antibody and antigen data.
    J Infect Dis. 2021 Oct 10. pii: 6386093. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. ODEDRA A, Woodford J, Chalon S, Barber BE, et al
    Letter Regarding Kamau et al: 2021 Safety and Tolerability of Mosquito-Bite Induced Controlled Human Infection with P. vivax in Malaria-Naive Study Participants - Clinical Profile and Utility of Molecular Diagnostic Methods.
    J Infect Dis. 2021 Oct 5. pii: 6381633. doi: 10.1093.
    PubMed    
    
    
    September 2021
65. PALASUWAN D, Palasuwan A, Boonpeng K, Ketprasit N, et al
    Impairment of invasion and maturation and decreased selectivity of Plasmodium falciparum in G6PD Viangchan and Mahidol variants.
    J Infect Dis. 2021 Sep 24. pii: 6374825. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
66. KREUTZFELD O, Tumwebaze PK, Byaruhanga O, Katairo T, et al
    Decreased susceptibility to dihydrofolate reductase inhibitors associated with genetic polymorphisms in Ugandan Plasmodium falciparum isolates.
    J Infect Dis. 2021 Aug 30. pii: 6359738. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. LUIZA-BATISTA C, Nardella F, Thiberge S, Serra-Hassoun M, et al
    Flowcytometric and ImageStream RNA-FISH gene expression, quantification and phenotypic characterization of blood and liver stages from human malaria species.
    J Infect Dis. 2021 Aug 28. pii: 6359056. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. WHITE NJ, Watson JA
    Questioning the Claimed Superiority of Malaria Parasite Ex Vivo Viability Reduction Over Observed Parasite Clearance Rate?
    J Infect Dis. 2021;224:738-739.
    PubMed    
    
    
    
69. CHUANG YM, Agunbiade TA, Tang XD, Freudzon M, et al
    The Effects of A Mosquito Salivary Protein on Sporozoite Traversal of Host Cells.
    J Infect Dis. 2021;224:544-553.
    PubMed     Abstract available
    
    
    July 2021
70. GUMBO A, Topazian HM, Mwanza A, Mitchell CL, et al
    Occurrence and Distribution of Non-falciparum Malaria Parasite Species among Adolescents and Adults in Malawi.
    J Infect Dis. 2021 Jul 9. pii: 6318237. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. ANDRONESCU LR, Sharma A, Peterson I, Kachingwe M, et al
    The effect of intermittent preventive treatment of malaria during pregnancy and placental malaria on infant risk of malaria.
    J Infect Dis. 2021 Jul 3. pii: 6314274. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. STRAIMER J, Gandhi P, Renner KC, Schmitt EK, et al
    High prevalence of P. falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine.
    J Infect Dis. 2021 Jul 3. pii: 6314293. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
73. KAMAU E, Bennett JW, Yadava A
    Safety and Tolerability of Mosquito-Bite Induced Controlled Human Infection with P. vivax in Malaria-Naive Study Participants - Clinical Profile and Utility of Molecular Diagnostic Methods.
    J Infect Dis. 2021 Jun 23. pii: 6308400. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
74. KANJEE U, Gruring C, Babar P, Meyers A, et al
    Plasmodium vivax Strains Use Alternative Pathways for Invasion.
    J Infect Dis. 2021;223:1817-1821.
    PubMed     Abstract available
    
    
    
75. MEIBALAN E, Barry A, Gibbins MP, Awandu S, et al
    Plasmodium falciparum Gametocyte Density and Infectivity in Peripheral Blood and Skin Tissue of Naturally Infected Parasite Carriers in Burkina Faso.
    J Infect Dis. 2021;223:1822-1830.
    PubMed     Abstract available
    
    
    
76. MAHON BE, Simon J, Widdowson MA, Samai M, et al
    Baseline Asymptomatic Malaria Infection and Immunogenicity of rVSVDeltaG-ZEBOV-GP Vaccine: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2021 May 20. pii: 6278485. doi: 10.1093.
    PubMed     Abstract available
    
    
    
77. SIMON N, Shallat J, Houck J, Jagannathan P, et al
    Peripheral Plasmodium falciparum infection in early pregnancy is associated with increased maternal microchimerism in the offspring.
    J Infect Dis. 2021 May 19. pii: 6278373. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. DRUETZ T, Stresman G, Ashton RA, Joseph V, et al
    The Immediate Effects of a Combined Mass Drug Administration and Indoor Residual Spraying Campaign to Accelerate Progress towards Malaria Elimination in Grande-Anse, Haiti.
    J Infect Dis. 2021 May 16. pii: 6276424. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2021
79. ROSAS-AGUIRRE A, Moreno M, Moreno-Gutierrez D, Llanos-Cuentas A, et al
    Integrating Parasitological and Entomological Observations to Understand Malaria Transmission in Riverine Villages in the Peruvian Amazon.
    J Infect Dis. 2021;223.
    PubMed     Abstract available
    
    
    
80. RODRIGUEZ-RODRIGUEZ D, Katusele M, Auwun A, Marem M, et al
    Human Behavior, Livelihood, and Malaria Transmission in Two Sites of Papua New Guinea.
    J Infect Dis. 2021;223.
    PubMed     Abstract available
    
    
    
81. HII J, Hustedt J, Bangs MJ
    Residual Malaria Transmission in Select Countries of Asia-Pacific Region: Old Wine in a New Barrel.
    J Infect Dis. 2021;223.
    PubMed     Abstract available
    
    
    
82. CARNEVALE P, Manguin S
    Review of Issues on Residual Malaria Transmission.
    J Infect Dis. 2021;223.
    PubMed     Abstract available
    
    
    
83. RODRIGUEZ MH
    Residual Malaria: Limitations of Current Vector Control Strategies to Eliminate Transmission in Residual Foci.
    J Infect Dis. 2021;223.
    PubMed     Abstract available
    
    
    
84. FOUQUE F, Knox T
    Special Programme for Research and Training in Tropical Diseases-coordinated Multicountry Study to Determine the Burden and Causes of Residual Malaria Across Different Regions.
    J Infect Dis. 2021;223.
    PubMed     Abstract available
    
    
    
85. OKUMU F, Finda M
    Key Characteristics of Residual Malaria Transmission in Two Districts in South-Eastern Tanzania-Implications for Improved Control.
    J Infect Dis. 2021;223.
    PubMed     Abstract available
    
    
    
86. BAMOU R, Rono M, Degefa T, Midega J, et al
    Entomological and Anthropological Factors Contributing to Persistent Malaria Transmission in Kenya, Ethiopia, and Cameroon.
    J Infect Dis. 2021;223.
    PubMed     Abstract available
    
    
    March 2021
87. ASUA V, Conrad MD, Aydemir O, Duvalsaint M, et al
    Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda.
    J Infect Dis. 2021;223:985-994.
    PubMed     Abstract available
    
    
    
88. MITCHELL CL, Brazeau NF, Keeler C, Mwandagalirwa MK, et al
    Under the Radar: Epidemiology of Plasmodium ovale in the Democratic Republic of the Congo.
    J Infect Dis. 2021;223:1005-1014.
    PubMed     Abstract available
    
    
    
89. HANSSON H, Minja DTR, Moeller SL, Lusingu JPA, et al
    Reduced birth weight caused by sextuple drug resistant Plasmodium falciparum infection in early 2nd trimester.
    J Infect Dis. 2021 Mar 4. pii: 6158222. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
90. RUBACH MP, Mukemba JP, Florence SM, Lopansri BK, et al
    Cerebrospinal fluid pterins, pterin-dependent neurotransmitters, and mortality in pediatric cerebral malaria.
    J Infect Dis. 2021 Feb 22. pii: 6146554. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. PINILLA YT, Boussougou-Sambe ST, Grassle S, Ngossanga B, et al
    Experimental Transmission of Plasmodium malariae to Anopheles gambiae.
    J Infect Dis. 2021;223:522-526.
    PubMed     Abstract available
    
    
    
92. SHRESTHA B, Shah Z, Morgan AP, Saingam P, et al
    Distribution and temporal dynamics of P. falciparum chloroquine resistance transporter mutations associated with piperaquine resistance in Northern Cambodia.
    J Infect Dis. 2021 Feb 2. pii: 6126500. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2021
93. GORRET AM, Muhindo R, Baguma E, Ntaro M, et al
    Comparison of capillary versus venous blood for the diagnosis of Plasmodium falciparum malaria using rapid diagnostic tests.
    J Infect Dis. 2021 Jan 27. pii: 6121365. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2020
94. WHITE NJ, Watson JA
    Is malaria parasite ex-vivo viability reduction really "superior" to observed parasite clearance rate?
    J Infect Dis. 2020 Dec 28. pii: 6053753. doi: 10.1093.
    PubMed    
    
    
    November 2020
95. SABOURIN KR, Daud I, Ogolla S, Labo N, et al
    Malaria is associated with Kaposi sarcoma-associated herpesvirus (KSHV) seroconversion in a cohort of western Kenyan children.
    J Infect Dis. 2020 Nov 29. pii: 6010567. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. DIGITALE JC, Callaway PC, Martin M, Nelson G, et al
    Inhibitory KIR ligands are associated with higher P. falciparum parasite prevalence.
    J Infect Dis. 2020 Nov 9. pii: 5962923. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2020
97. NAING C, Whittaker MA, Tanner M
    Multisectoral Approach to Support Use of Insecticide-Treated Net for Malaria Prevention Among Mobile and Migrant Populations in Myanmar: A Systematic Review.
    J Infect Dis. 2020;222.
    PubMed     Abstract available
    
    
    
98. JONES RT, Tusting LS, Smith HMP, Segbaya S, et al
    The Role of the Private Sector in Supporting Malaria Control in Resource Development Settings.
    J Infect Dis. 2020;222.
    PubMed     Abstract available
    
    
    
99. REBELO M, Pawliw R, Gower J, Webb L, et al
    Parasite viability is a superior measure of anti-malarial drug activity in humans.
    J Infect Dis. 2020 Oct 29. pii: 5943003. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. DEUTSCH-FELDMAN M, Parr JB, Keeler C, Brazeau NF, et al
     What is the burden of malaria in the DRC?
     J Infect Dis. 2020 Oct 15. pii: 5923744. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2020
101. FRIEDMAN-KLABANOFF DJ, Travassos MA, Ifeonu OO, Agrawal S, et al
     Epitope-specific antibody responses to a Plasmodium falciparum subunit vaccine target in a malaria-endemic population.
     J Infect Dis. 2020 Sep 29. pii: 5913015. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. SINGH H, Mian SY, Pandey AK, Krishna S, et al
     Antibody combinations targeting the essential antigens CyRPA, RH5 and MSP-119 potently neutralize Plasmodium falciparum clinical isolates from India and Africa.
     J Infect Dis. 2020 Sep 29. pii: 5912652. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. PEATEY C, Chen N, Gresty K, Anderson K, et al
     Dormant Plasmodium falciparum parasites in human infections following artesunate therapy.
     J Infect Dis. 2020 Sep 9. pii: 5903078. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2020
104. TESSEMA SK, Hathaway NJ, Teyssier NB, Murphy M, et al
     Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome.
     J Infect Dis. 2020 Aug 25. pii: 5897005. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. ROSAS-AGUIRRE A, Guzman-Guzman M, Chuquiyauri R, Moreno M, et al
     Temporal and micro-spatial heterogeneity in transmission dynamics of co-endemic Plasmodium vivax and Plasmodium falciparum in two rural cohort populations in the Peruvian Amazon.
     J Infect Dis. 2020 Aug 21. pii: 5895494. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. STEPNIEWSKA K, Humphreys GS, Goncalves BP, Craig E, et al
     Efficacy of single dose primaquine with artemisinin combination therapy on P. falciparum gametocytes and transmission: A WWARN individual patient meta-analysis.
     J Infect Dis. 2020 Aug 11. pii: 5890806. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2020
107. MCCALL MBB, Yap XZ, Bousema T
     Optimizing RTS,S vaccination strategies: give it your best parting shot.
     J Infect Dis. 2020 Jul 20. pii: 5873653. doi: 10.1093.
     PubMed    
     
     
     June 2020
108. MHARAKURWA S, Matsena-Zingoni Z, Mudare N, Matimba C, et al
     Steep rebound of chloroquine sensitive Plasmodium falciparum in Zimbabwe.
     J Infect Dis. 2020 Jun 28. pii: 5864225. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. MOUSSILIOU A, Turner L, Cottrell G, Doritchamou J, et al
     Dynamics of PfEMP1 Antibody Profile From Birth to 12 Months of Age in Beninese Infants.
     J Infect Dis. 2020;221:2010-2017.
     PubMed     Abstract available
     
     
     May 2020
110. NARH CA, Ghansah A, Duffy MF, Ruybal-Pesantez S, et al
     Evolution of antimalarial drug resistance markers in the reservoir of Plasmodium falciparum infections in the Upper East Region of Ghana.
     J Infect Dis. 2020 May 27. pii: 5847780. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. GIBBONS J, Qin J, Malla P, Wang Z, et al
     Lineage-specific expansion of Plasmodium falciparum parasites with pfhrp2 deletion in the Greater Mekong Subregion.
     J Infect Dis. 2020 May 9. pii: 5835314. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2020
112. TAYLOR SM, Levitt B, Freedman B, Madanitsa M, et al
     Interactions between antenatal sulfadoxine-pyrimethamine, drug-resistant Plasmodium falciparum parasites and delivery outcomes in Malawi.
     J Infect Dis. 2020 Mar 28. pii: 5812943. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. SUTHERLAND CJ
     A New Window on Plasmodium malariae Infections.
     J Infect Dis. 2020;221:864-866.
     PubMed    
     
     
     
114. WOODFORD J, Collins KA, Odedra A, Wang C, et al
     An Experimental Human Blood-Stage Model for Studying Plasmodium malariae Infection.
     J Infect Dis. 2020;221:948-955.
     PubMed     Abstract available
     
     
     November 2019
115. HUIJBEN S, Macete E, Mombo-Ngoma G, Ramharter M, et al
     Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
     J Infect Dis. 2019 Nov 2. pii: 5611162. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Malaria is free of charge.